MusclePharm Financials

MusclePharm Key Financial Ratios

MusclePharm's financial ratios allow both analysts and investors to convert raw data from MusclePharm's financial statements into concise, actionable information that can be used to evaluate the performance of MusclePharm over time and compare it to other companies across industries.

MusclePharm Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining MusclePharm's current stock value. Our valuation model uses many indicators to compare MusclePharm value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across MusclePharm competition to find correlations between indicators driving MusclePharm's intrinsic value. More Info.MusclePharm is rated top company in revenue category among its peers. It also is considered to be number one stock in ebitda category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the MusclePharm's earnings, one of the primary drivers of an investment's value.

MusclePharm Market Pulse

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.

If you are still planning to invest in MusclePharm check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MusclePharm's history and understand the potential risks before investing.